Aim . To study novel biomarkers, as well as clinical and morphological features of myocardial remodeling, in patients with the diabetic phenotype (DP) of heart failure with preserved ejection fraction (HFpEF) hospitalized for elective coronary artery bypass grafting. Material and methods. A total of 120 patients of both sexes with stage I-IIA, class I-III HFpEF (60+60) (with or without type 2 diabetes (T2D)), and underlying coronary artery disease and hypertension were studied. In addition to standard examinations, blood levels of N-terminal pro-brain natriuretic peptide and oxytocin were measured, along with assessment of left ventricular (LV) myocardial remodeling and diastolic dysfunction types. The global LV function index was calculated, and general histological and immunohistochemical (caspase-3, bcl-2, ki- 67, and oxytocin receptors) investigations of right atrial appendage myocardial biopsies were performed. Results . Myocardial remodeling in DP of HFpEF was characterized by the predominance of eccentric hypertrophy (43%), type 2 diastolic dysfunction (p=0,028), lower LV ejection fraction (p=0,002), and lower LV global function index (p=0,042) compared to patients without T2D. The morphological profile of the myocardium in DP of HFpEF demonstrated significant activation of angiogenesis (p=0,006), apoptosis (p<0,001), and proliferative potential of cardiomyocytes (p=0,049). The identified changes were accompanied by a significant decrease in blood oxytocin level (p<0,001) and high expression of oxytocin receptors (p<0,001) in the myocardium of patients with DP of HFpEF compared to the group without T2D. Conclusion . A distinctive feature of the myocardial remodeling marker panel in patients with HFpEF in this study was a low blood oxytocin level and a high cardiomyocyte apoptosis index.